Avoro Capital Advisors LLC Taysha Gene Therapies, Inc. Transaction History
Avoro Capital Advisors LLC
- $7.32 Billion
- Q3 2025
A detailed history of Avoro Capital Advisors LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 21,700,000 shares of TSHA stock, worth $91.4 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
21,700,000
Previous 21,700,000
-0.0%
Holding current value
$91.4 Million
Previous $50.1 Million
36.36%
% of portfolio
0.93%
Previous 0.91%
Shares
5 transactions
Others Institutions Holding TSHA
# of Institutions
161Shares Held
247MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$54.1 Million0.0% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...